Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Polyelectrolyte microcapsules: antigen delivery vehicles for potent induction of CTL responses (131.34)

Johan Grooten, Bruno De Geest, Thomas Naessens, Stefaan De Smedt and Stefaan De Koker
J Immunol April 1, 2010, 184 (1 Supplement) 131.34;
Johan Grooten
1University Ghent, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno De Geest
1University Ghent, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Naessens
1University Ghent, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefaan De Smedt
1University Ghent, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefaan De Koker
1University Ghent, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Developing effective cancer vaccines is thought to require the strong activation of cytotoxic T cells (CTLs) to kill transformed cells. Initiation of such CTL responses requires DCs presenting the antigen via the MHCI route, a feature hardly achievable using soluble antigens. Internalization of particulate antigens in contrast has been shown to strongly promote MHCI mediated antigen presentation. In this study, ovalbumin (OVA) was encapsulated in polyelectrolyte microcapsules (PEM), a new class of particles allowing efficient antigen encapsulation under non-denaturing conditions. OVA-loaded PEM strongly promoted MHCI mediated OVA presentation by DCs in vitro and in vivo. Being attractive tools to enhance antigen presentation, PEM however fail to activate DCs, a prerequisite for the initiation of potent CTL responses. To cope with this issue, we coated the surface of cationic PEM with oligonucleotides containing unmethylated CpG motifs, which are strong activators of DCs by triggering TLR9. Co-delivery of CpG and OVA-loaded microcapsules synergistically increased the strength of the CTL response, indicated by a dramatic increase in the number of IFN-γ secreting CTLs and a strongly enhanced killing of OVA peptide-pulsed splenocytes after adoptive transfer. Finally, immunisation with CpG-modified capsules was able to confer protective immunity against a lethal challenge with the highly aggressive OVA-transduced B16 melanoma, clearly demonstrating the potential of this approach.

  • Copyright © 2010 by The American Association of Immunologists, Inc.
Previous
Back to top

In this issue

The Journal of Immunology
Vol. 184, Issue 1 Supplement
April 2010
  • Table of Contents
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Polyelectrolyte microcapsules: antigen delivery vehicles for potent induction of CTL responses (131.34)
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Polyelectrolyte microcapsules: antigen delivery vehicles for potent induction of CTL responses (131.34)
Johan Grooten, Bruno De Geest, Thomas Naessens, Stefaan De Smedt, Stefaan De Koker
The Journal of Immunology April 1, 2010, 184 (1 Supplement) 131.34;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Polyelectrolyte microcapsules: antigen delivery vehicles for potent induction of CTL responses (131.34)
Johan Grooten, Bruno De Geest, Thomas Naessens, Stefaan De Smedt, Stefaan De Koker
The Journal of Immunology April 1, 2010, 184 (1 Supplement) 131.34;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

  • Activation of omental immune aggregates: a potential tumor therapy (131.37)
  • Naïve tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma (131.12)
  • Immunization with lentivector expressing HBV Ag markedly improves the tumor microenvironment and result in regression of established tumors (131.44)
Show more Cancer Immunotherapy

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606